Cargando…
Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster
SIMPLE SUMMARY: Understanding how a virus interacts with cellular targets in an animal model provides critical information in developing therapeutic targets and vaccines for humans. The Syrian hamster model of SARS-CoV-2 infection, the causative agent of COVID-19, is one of the most widely used anim...
Autores principales: | Clancy, Chad S., Meade-White, Kimberly, Shaia, Carl, Saturday, Greg, Feldmann, Heinz, Rosenke, Kyle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536131/ https://www.ncbi.nlm.nih.gov/pubmed/37756057 http://dx.doi.org/10.3390/vetsci10090536 |
Ejemplares similares
-
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
por: Rosenke, Kyle, et al.
Publicado: (2020) -
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
por: Rosenke, Kyle, et al.
Publicado: (2020) -
Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
por: Rosenke, Kyle, et al.
Publicado: (2022) -
SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
por: Hansen, Frederick, et al.
Publicado: (2022) -
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2020)